STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.
企業コードSTAA
会社名STAAR Surgical Co
上場日Feb 24, 1992
最高経営責任者「CEO」Mr. Stephen C. (Steve) Farrell, CPA
従業員数1157
証券種類Ordinary Share
決算期末Feb 24
本社所在地1911 Walker Ave
都市MONROVIA
証券取引所NASDAQ Global Market Consolidated
国United States of America
郵便番号91016
電話番号16263037902
ウェブサイトhttps://www.staar.com/
企業コードSTAA
上場日Feb 24, 1992
最高経営責任者「CEO」Mr. Stephen C. (Steve) Farrell, CPA
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし